Lamusta-N

Lamusta-N

Lamusta N product has three antiretroviral compositions: Lamivudine 150mg, Stavudine 40mg, and Nevirapine 200mg. Lamivudine and Stavudine are known as nucleotide reverse transcriptase. Nevirapine belongs to the medicine non-nucleoside reverse transcriptase. The human immunodeficiency virus that causes acquired immunodeficiency syndrome. Treatment involves a combination of antiretroviral tablets to prevent HIV infection.

HIV and ARV Products Exporter

Lamivudine has anti-hepatitis B virus properties. It is metabolized inside cells to produce lamivudine 5'-triphosphate, the active form. It mainly acts as a chain terminator for viral reverse transcriptase. Inside the cells, lamivudine works effectively against HIV clinical isolates.

Nevirapine binds to reverse transcriptase and changes the enzyme's catalytic site, disabling its ability to synthesize DNA from RNA and DNA templates. Stavudine triphosphate reduces mitochondrial DNA production and inhibits gamma and beta cells. Also, increasing CD4 cell counts. CD4 cells are important for maintaining a strong immune system, that helps fight off illnesses. Stavudine works with deoxythymidine triphosphate to block the function of human immunodeficiency virus reverse transcriptase.

Lamivudine, Stavudine, and Nevirapine Products Manufacturing Company

Sunrise Remedies is a leading manufacturer, supplier, and exporter of Nevirapine tablets, including Lamivudine, Stavudine, and Nevirapine under the brand name “Lamusta N.” We are a top pharma company specializing life saving products and treatments for HIV and antiretroviral therapies.

As an ISO and WHO GMP certified manufacturer, Sunrise Remedies ensures strict quality testing and reliability for the product. We prioritize strong formulations and are among the most recognized global exporters and bulk providers in the market.

Sunrise Remedies provides third-party and contract manufacturing services, especially in HIV and antiretroviral (ARV), and also offers manufacturing for a big range of other pharma formulations. Its WHO-GMP-certified facility is able to produce a diverse portfolio, including tablets, capsules, liquids, and dry syrup powder.

• COMPOSITION
• MODE OF USE
• WARNINGS